IMA vs REG · rev $9.2M vs P/E 34, $12.93B cap
ImageneBio, Inc. (IMA) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
REG does not have a complete income-statement cache yet.
IMA currently screens at market cap $64.7M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the IMA and REG stock pages for the full models.
Not investment advice.